Sodium Iodide (131i) Diagnostic Ge Healthcare

Sodium Iodide (131I) is a radiopharmaceutical used in diagnostic imaging for thyroid function assessment. This oral solution helps detect thyroid disorders by measuring iodine uptake. Short half-life ensures minimal radiation exposure. Ideal for thyroid imaging and uptake studies.

Sodium Iodide (131I) is primarily used for diagnostic imaging of the thyroid gland. It helps identify thyroid nodules, hyperthyroidism, and other thyroid-related conditions by evaluating iodine uptake. This radiopharmaceutical is also used in thyroid cancer follow-up scans. It provides critical insights for healthcare professionals assessing thyroid health.

After oral administration, Sodium Iodide (131I) is absorbed by the thyroid gland, where it emits radiation detectable by imaging equipment. The solution may cause a metallic taste or mild nausea in some individuals. Temporary thyroid suppression is a known physiological response following administration. Most effects are transient and resolve without intervention.

Sodium Iodide (131I) should be handled with care due to its radioactive properties. Pregnant or breastfeeding individuals should avoid use unless medically necessary. Patients must follow healthcare provider instructions for preparation and post-administration precautions. Avoid close contact with others for a specified period to minimize radiation exposure to bystanders.

Certain medications, such as thyroid hormones or iodine-containing supplements, may interfere with Sodium Iodide (131I) uptake. Patients should disclose all medications and supplements to their healthcare provider before administration. Foods high in iodine, like seaweed or iodized salt, may also affect results. Alcohol and caffeine do not directly interact but may be restricted for other clinical reasons.